Earum Pharmaceuticals IPO vs Gensol Engineering IPO
Comparison between Earum Pharmaceuticals IPO and Gensol Engineering IPO.
IPO Details
Earum Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Gensol Engineering IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Gensol Engineering IPO is up to ₹17.02 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Gensol Engineering IPO is ₹83.00 per share.
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Gensol Engineering IPO opens on Sep 30, 2019. The closing date of Earum Pharmaceuticals IPO and Gensol Engineering IPO is Jun 26, 2019, and Oct 04, 2019, respectively.
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Gensol Engineering IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Gensol Engineering IPO.